Email
IZ Express #1,682: CDC updates recs on hepatitis B virus screening
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,682: CDC updates recs on hepatitis B virus screening |
| Date | March 15, 2023 10:01 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed] [link removed] [link removed] [link removed] [link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,682: March 15, 2023
Top Stories
* CDC updates and expands its screening recommendations for hepatitis B virus infection in the United States
* FDA approves intramuscular injection as an option, in addition to subcutaneous administration, for M-M-R II, Varivax, and ProQuad vaccines
* March is Women’s History Month; Immunize.org celebrates the many contributions of women in vaccinology
* Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
* Influenza activity remains low nationally but is still circulating; keep encouraging vaccination
* Spotlight: Immunize.org's “Clinic Tools: Administering Vaccines” main page provides practical tools based on authoritative sources
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates "Talking about Vaccines" web pages on alternative schedules, autism, and MMR vaccine
Vaccine Information Statements
* Immunize.org posts 19 new and updated Vaccine Information Statements in Bengali
* Immunize.org posts 11 new and updated Vaccine Information Statements in Hmong
* Immunize.org posts 15 new and updated Vaccine Information Statements in Thai
Featured Resources
* Society for Women’s Health Research releases video series to help people learn about HPV vaccine and cancer prevention
* Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
* CHOP's Vaccine Education Center offers video on measles symptoms, spread, and complications
* Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available on-demand
* Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
* Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Upcoming Events
* Virtual: NFID hosts webinar “Updates from February 2023 Advisory Committee on Immunization Practices (ACIP) Meeting” on March 22; CME available
* Virtual: Massachusetts Adult Immunization Coalition hosts “28th Annual Massachusetts Adult Immunization Conference” on April 4; CME available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC updates and expands its screening recommendations for hepatitis B virus infection in the United States
CDC published Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations—United States, 2023 ([link removed]) on March 10 in MMWR. The report updates previous guidelines, now recommending that all adults be screened for HBV infection with a triple-panel test at least once in their lifetimes.
The new guidelines also recommend that people who are not vaccinated for hepatitis B, but are at increased risk of HBV infection, receive periodic testing. Risk-based testing is expanded to include more conditions:
* People incarcerated or formerly incarcerated in a jail, prison, or other detention setting
* People with a history of sexually transmitted infections or multiple sex partners
* People with a history of hepatitis C virus infection
Anyone can be infected with hepatitis B. Because risk may be transient or unrecognized, all adults can benefit from knowing their status and being protected from infection. To provide increased access to testing, anyone who requests HBV testing should receive it, regardless of disclosure of risk. In addition to screening, CDC recommends vaccination of all people younger than age 60 years and all people age 60 or older at increased risk. Anyone age 60 or older may be vaccinated.
A person who is unvaccinated may have blood drawn for screening, followed by the first dose of vaccine at the same visit. If vaccination is indicated, it should not be delayed if screening is not feasible.
[link removed]
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Links
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
* CDC: Viral Hepatitis: Hepatitis B ([link removed]) main page
* Immunize.org: Vaccines: Hepatitis B ([link removed]) main page
------------------------------------------------------------
FDA approves intramuscular injection as an option, in addition to subcutaneous administration, for M-M-R II, Varivax, and ProQuad vaccines
The Food and Drug Administration (FDA) approved intramuscular (IM) injection as an option for M-M-R II (measles-mumps-rubella vaccine), Varivax (varicella vaccine), and ProQuad (measles-mumps-rubella-varicella vaccine) from Merck. Previously, these vaccines were only licensed for subcutaneous (subcut) injection.
Two brands of MMR vaccine are distributed in the United States. Only Merck’s brand is licensed for either IM or subcut administration. Priorix from GSK is licensed for subcut administration. In coming weeks, Immunize.org will update its resources on vaccine administration to reflect this new route of administration option.
Related Links
* FDA: Measles, Mumps, and Rubella Virus Vaccine Live (M-M-R II) ([link removed]) protect information
* FDA: Measles, Mumps, Rubella, and Varicella Virus ([link removed]) Live (ProQuad) ([link removed]) product information
* FDA: Varicella Virus Vaccine ([link removed]) (Varivax) ([link removed]) product information
* Merck press release: U.S. FDA Approves Intramuscular Administration for Merck’s MMRV Family of Vaccines: M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live), Varivax (Varicella Virus Vaccine Live), and ProQuad (Measles, Mumps, Rubella, and Varicella Virus Vaccine Live) ([link removed]) (3/6/23)
* Immunize.org: Food and Drug Administration: Package Inserts & FDA Product Approvals ([link removed]) main page
------------------------------------------------------------
March is Women’s History Month; Immunize.org celebrates the many contributions of women in vaccinology
March is Women's History Month ([link removed]) and Immunize.org acknowledges the important contributions of women to vaccinology. Since the beginning of the vaccine era, women contributed to vaccine science and vaccination programs globally. We celebrate women’s trailblazing contributions in vaccinology, including:
* Lady Mary Wortley Montagu introduced smallpox inoculation to Britain and Western Europe in 1721
* Anna Wessels Williams isolated the reference strain of diphtheria used to develop the first diphtheria antitoxin and later a diphtheria toxoid in the 1890s. She developed a quick test to diagnose rabies in 1902.
* Margaret Pittman recognized in 1931 that type b of Haemophilus influenzae was a major cause of disease
* Ida A. Bengtson developed the complement fixation test in the 1920s, which was used to standardize units of biological activity for botulinum, gas gangrene, and other antitoxins
* Pearl L. Kendrick and Grace Elderling researched pertussis in the 1940s, tested their vaccine first on themselves, and ran a successful clinical trial, resulting in the first vaccine against pertussis. Loney Clinton Gordon aided their efforts.
* Dorothy Horstmann showed that poliovirus reaches the brain through the blood in the 1940s
* Clara I. Nigg codeveloped botulinum toxoids in 1947
* Isabel M. Morgan and her team proved that inactivated viruses could produce immunity in the 1940s; her work led the development of Salk's polio vaccine in 1955
* Brigitte Alice Askonas's work on antibodies and T-cells in the 1950s informed research to improve vaccines
* Ruth L. Kirshstein helped develop and refine tests to assure the safety of viral vaccines against polio, measles, and rubella in the 1950s–1970s
* Özlem Türeci helped lead the development of the BioNTech/Pfizer COVID-19 vaccine in 2020
* Lisa Jackson led the world's first COVID-19 clinical vaccine trial in 2020
* Kizzmekia Corbett helped create the COVID-19 mRNA vaccine in 2020
* These are a few of the countless women contributing to vaccine development and the success of vaccination programs worldwide
[link removed]
The contributions of all of the women who work tirelessly to advance vaccine science, policy, and program implementation are deeply appreciated.
Related Links
* Women's History Month ([link removed]) website
* Gavi, the Vaccine Alliance: The Women Who Made Modern Vaccines Work ([link removed]) web page
* International Vaccine Institute: Celebration Women in Vaccines – International Day of Women and Girls in Science 2023 ([link removed]) web page
------------------------------------------------------------
Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
The Immunize.org reviews and updates the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) every month, prominently indicating when it was last updated at the top of the page. This month’s updates are minimal, including an updated FDA page on expiration dates and the date of the Immunize.org Vaccines: COVID-19 ([link removed]) main page.
All COVID-19 vaccination providers should review the checklist regularly to be sure practices stay up to date.
[link removed]
CDC posted a spotlight on influenza vaccine effectiveness (VE) ([link removed]) this season. Multiple estimates show that influenza vaccine provides substantial protection to children and adults this season against illness and hospitalization.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
------------------------------------------------------------
Influenza activity remains low nationally but is still circulating; keep encouraging vaccination
CDC continues to recommend influenza vaccination for those not yet protected as long as influenza is circulating. Keep in mind young children who still need a second dose in their first vaccination season and those who need vaccination during pregnancy.
CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , provides a valuable snapshot of influenza activity state by state. For week 9, ending March 4, FluView ([link removed]) reports that 2.4% of outpatient visits nationwide were due to respiratory illness that included fever plus a cough or sore throat (i.e., influenza-like illness [ILI]). The national baseline is 2.5%. Multiple respiratory viruses are co-circulating; the relative contribution of influenza virus infection to ILI varies by location. So far this season, 125 children died from influenza-associated causes.
[link removed]
Influenza Vaccination Dashboard
CDC’s Weekly Flu Vaccination Dashboard ([link removed]) shows that vaccination coverage for all children remains 2.3 percentage points lower compared with same time in February 2021 (53.0% compared with 55.3%). Where children live is strongly associated with how likely they are to be vaccinated: the influenza vaccination rate among rural children is 19.1 percentage points lower compared with children living in urban areas (37.5% compared with 56.7%).
CDC posted a spotlight on influenza vaccine effectiveness (VE) ([link removed]) this season. Multiple estimates show that this season, influenza vaccine provides substantial protection against illness and hospitalization to children and adults.
CDC recommends everyone age 6 months and older get annual influenza vaccination. “Vaccines.gov” offers VaccineFinder ([link removed]) , a service of Boston Children’s Hospital, to help people find influenza and COVID-19 vaccines for any age group. To be listed as a provider by VaccineFinder, see the information at this website ([link removed]) .
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: Influenza (Flu) ([link removed]) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
------------------------------------------------------------
Spotlight: Immunize.org's “Clinic Tools: Administering Vaccines” main page provides practical tools based on authoritative sources
Immunize.org's Clinic Tools: Administering Vaccines ([link removed]) main page is a collection of resources from Immunize.org, CDC, and other organizations. To find it, select the "Clinic Tools" tab in the middle of the blue banner atop every Immunize.org web page and then select "Administering Vaccines."
On the "Clinic Tools: Administering Vaccines" main page, you will find educational materials such as:
* Administering Vaccines: Dose, Route, Site, and Needle Size ([link removed])
* Don’t Be Guilty of These Preventable Errors in Vaccine Administration ([link removed])
* How to Administer Intramuscular and Subcutaneous Vaccine Injections ([link removed])
* Skills Checklist for Vaccine Administration ([link removed])
The right-hand column of the page features partner resources, links to vaccine administration guidelines, and The Epidemiology and Prevention of Vaccine-Preventable Diseases ("The Pink Book") textbook.
[link removed]
Visit the Clinic Tools: Administering Vaccines ([link removed]) main page on Immunize.org.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* AMA: Why COVID-19 Deaths among Vaccinated Show That Boosters Matter ([link removed]) (3/7/23)
* U.S. News: Highlighting Link between Flu & Heart Trouble Can Nudge Folks to Get Vaccine ([link removed] ) (3/7/23)
* ABC: MMR Vaccine Rates Are Lagging amid a Rise in Measles Cases. Experts Blame a Discredited Study. ([link removed]) (3/6/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates "Talking about Vaccines" web pages on alternative schedules, autism, and MMR vaccine
Immunize.org updated Talking about Vaccines: A ([link removed]) lternative Schedules ([link removed]) , Talking about Vaccines: Autism ([link removed]) , and Talking about Vaccines: MMR Vaccine ([link removed]) main pages. These pages lead to many resources from Immunize.org, CDC, and others to help healthcare professionals communicate with parents and patients about important vaccine topics.
The pages were updated to optimize links and content.
[link removed] [link removed] [link removed]
Related Links
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed]) —an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
* Immunize.org: Talking about Vaccines ([link removed]) main page
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Immunize.org posts 19 new and updated Vaccine Information Statements in Bengali
Immunize.org further expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. With CDC funding to increase the availability of translations, 19 new VIS translations were added in Bengali.
All translations are available in print-ready PDF format.
New VIS translations in Bengali ([link removed]) :
* Updated: DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Updated: Hepatitis A ([link removed]) VIS
* Updated: Hepatitis B ([link removed]) VIS
* Updated: Haemophilus influenzae type b (Hib) ([link removed]) VIS
* Updated: HPV (Human Papillomavirus) ([link removed]) VIS
* Updated: Influenza (Inactivated or Recombinant) ([link removed]) VIS
* Updated: Influenza (Live Intranasal) ([link removed]) VIS
* Updated: Meningococcal ACWY ([link removed]) VIS
* Updated: Meningococcal B ([link removed]) VIS
* Updated: MMR (Measles, Mumps, and Rubella) ([link removed]) VIS
* Updated: MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* Updated: Polio ([link removed]) VIS
* New! Rabies ([link removed]) VIS
* New! Rotavirus ([link removed]) VIS
* New! Smallpox/Monkeypox ([link removed]) VIS
* Updated: Td (Tetanus, Diphtheria) ([link removed]) VIS
* Updated: Tdap (Tetanus, Diphtheria, Pertussis) ([link removed]) VIS
* Updated: Varicella (Chickenpox) ([link removed]) VIS
* New! Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Bengali-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org posts 11 new and updated Vaccine Information Statements in Hmong
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. With CDC funding to increase the availability of translations, 11 new VIS translations were added in Hmong.
All translations are available in print-ready PDF format.
New VIS translations in Hmong ([link removed]) :
* New! DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Updated: Hepatitis A ([link removed]) VIS
* Updated: Hepatitis B ([link removed]) VIS
* Updated: Haemophilus influenzae type b (Hib) ([link removed]) VIS
* New! Meningococcal ACWY ([link removed]) VIS
* Updated: Meningococcal B ([link removed]) VIS
* Updated: Polio ([link removed]) VIS
* New! Rabies ([link removed]) VIS
* New! Smallpox/Monkeypox ([link removed]) VIS
* Updated: Td (Tetanus, Diphtheria) ([link removed]) VIS
* Updated: Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Hmong-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org posts 15 new and updated Vaccine Information Statements in Thai
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. With CDC funding to increase the availability of translations, 15 new VIS translations were added in Thai.
All translations are available in print-ready PDF format.
New VIS translations in Thai ([link removed]) :
* Updated: DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* New! Hepatitis A ([link removed]) VIS
* Updated: Hepatitis B ([link removed]) VIS
* New! Haemophilus influenzae type b (Hib) ([link removed]) VIS
* Updated: HPV (Human Papillomavirus) ([link removed]) VIS
* Updated: Meningococcal ACWY ([link removed]) VIS
* Updated: Meningococcal B ([link removed]) VIS
* Updated: MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* New! Polio ([link removed]) VIS
* New! Rabies ([link removed]) VIS
* New! Rotavirus ([link removed]) VIS
* New! Smallpox/Monkeypox ([link removed]) VIS
* New! Td (Tetanus, Diphtheria) ([link removed]) VIS
* Updated: Varicella (Chickenpox) ([link removed]) VIS
* Updated: Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Thai-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Society for Women’s Health Research releases video series to help people learn about HPV vaccine and cancer prevention
The Society for Women's Health Research launched its #SWHRtalksHPV Video Series ([link removed]) to help parents and guardians learn about cancer prevention via HPV vaccination. Experts share facts and insights as they answer key questions.
The series of ten videos features Immunize.org’s chief policy and partnerships officer, L.J Tan, PhD, MS.
[link removed]
Share the video series on social media and with your networks, and tag @SWHR and #SWHRtalksHPV.
Back to top (#Top)
------------------------------------------------------------
Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
[link removed] [link removed]
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
CHOP's Vaccine Education Center offers video on measles symptoms, spread, and complications
Children's Hospital of Philadelphia's (CHOP) Vaccine Education Center (VEC) offers Measles: Symptoms, Spread & SSPE ([link removed]) in its Doctors Talk video series. In this video, CHOP's Paul Offit, MD, and Katie Lockwood, MD, MEd, talk about measles, its symptoms, side effects, and physician worries when a child contracts measles.
[link removed]
Watch and share the video ([link removed]) .
Related Links
* CHOP VEC: A Look at Each Vaccine: Measles, Mumps and Rubella (MMR) Vaccine ([link removed]) web page
* CHOP VEC: Measles, Mumps & Rubella (MMR) Infographic ([link removed]) (PDF)
------------------------------------------------------------
Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available on-demand
On February 28, Immunize.org and Canadian experts from the Hospital for Sick Children (SickKids), Toronto, and Society for Infodemic Management, Québec, hosted a 1-hour webinar, Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults ([link removed]) . During this webinar, participants learned about the principles behind vaccination pain and anxiety and simple, evidence-based strategies to reduce apprehension. These strategies were developed by the experts from HELP Eliminate Pain in Kids and Adults ([link removed]) . Their work was used by the World Health Organization (WHO), Public Health Canada, and others to develop guidelines for reducing vaccination pain.
The video of the webinar, slide set, and web links to other resources are now available on our website for on-demand viewing ([link removed]) . Please view and share this important webinar with your colleagues.
[link removed]
Related Link
* Immunize.org: Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age ([link removed]) (webinar held on 12/13/22)
------------------------------------------------------------
Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident recommendations for influenza vaccine from healthcare providers are powerfully persuasive. To assist you in maximizing protection for your patients, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense ([link removed]) website.
Older adults are at increased risk of severe influenza and COVID-19 illness, including hospitalization and death, especially if they are not up to date on these vaccinations. An updated fact sheet on the website, The Importance of Preventing Influenza and COVID-19, ([link removed]) ([link removed]) offers responses to help guide discussions with patients on the importance of preventing influenza and COVID-19.
[link removed]
This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP ([link removed])
* The Importance of Preventing Influenza and COVID-19 ([link removed])
Check out the updated 65+ Flu Defense website at www.influenza-defense.org ([link removed]) to assist your ongoing efforts in protecting this vulnerable population.
------------------------------------------------------------
Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Download Immunize.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide is available to download/print either by chapter or in its entirety free at www.immunize.org/guide ([link removed]) . The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s educational materials (handouts) on adult immunization ([link removed])
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: NFID hosts webinar “Updates from February 2023 Advisory Committee on Immunization Practices (ACIP) Meeting” on March 22; CME available
The National Foundation for Infectious Diseases will host a webinar titled Updates from February 2023 Advisory Committee on Immunization Practices (ACIP) Meeting ([link removed]) , 12:00–1:00 p.m. (ET) on March 22. During the webinar, William Schaffner, MD, NFID Medical Director and ACIP liaison, and Jessica R. MacNeil, MPH, ACIP Deputy Executive Secretary, will discuss the updates to current U.S. vaccination recommendations for children, adolescents, and adults. Content will focus primarily on non-COVID-19-related topics.
There is no fee to participate in this activity, but pre-registration is required. CME available.
Register for the webinar ([link removed]) .
------------------------------------------------------------
Virtual: Massachusetts Adult Immunization Coalition hosts “28th Annual Massachusetts Adult Immunization Conference” on April 4; CME available
Massachusetts Adult Immunization Coalition (MAIC) will host its 28th Annual Massachusetts Adult Immunization Conference ([link removed]) virtually, 8:00 a.m.–4:00 p.m. (ET), on April 4. This year's theme is the future of vaccination.
The goal is to educate healthcare professionals on best practices for adult immunization. The 2023 conference offers an opportunity to receive the most updated information on routine adult immunization from leading experts and network with experts and colleagues.
Professionals outside of Massachusetts are encouraged to attend. First-time attendees get free registration; $50 for students and $75 for others. Up to 6.75 CME credits are available.
Register for the conference ([link removed]) .
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,682: March 15, 2023
Top Stories
* CDC updates and expands its screening recommendations for hepatitis B virus infection in the United States
* FDA approves intramuscular injection as an option, in addition to subcutaneous administration, for M-M-R II, Varivax, and ProQuad vaccines
* March is Women’s History Month; Immunize.org celebrates the many contributions of women in vaccinology
* Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
* Influenza activity remains low nationally but is still circulating; keep encouraging vaccination
* Spotlight: Immunize.org's “Clinic Tools: Administering Vaccines” main page provides practical tools based on authoritative sources
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates "Talking about Vaccines" web pages on alternative schedules, autism, and MMR vaccine
Vaccine Information Statements
* Immunize.org posts 19 new and updated Vaccine Information Statements in Bengali
* Immunize.org posts 11 new and updated Vaccine Information Statements in Hmong
* Immunize.org posts 15 new and updated Vaccine Information Statements in Thai
Featured Resources
* Society for Women’s Health Research releases video series to help people learn about HPV vaccine and cancer prevention
* Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
* CHOP's Vaccine Education Center offers video on measles symptoms, spread, and complications
* Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available on-demand
* Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
* Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Upcoming Events
* Virtual: NFID hosts webinar “Updates from February 2023 Advisory Committee on Immunization Practices (ACIP) Meeting” on March 22; CME available
* Virtual: Massachusetts Adult Immunization Coalition hosts “28th Annual Massachusetts Adult Immunization Conference” on April 4; CME available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC updates and expands its screening recommendations for hepatitis B virus infection in the United States
CDC published Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations—United States, 2023 ([link removed]) on March 10 in MMWR. The report updates previous guidelines, now recommending that all adults be screened for HBV infection with a triple-panel test at least once in their lifetimes.
The new guidelines also recommend that people who are not vaccinated for hepatitis B, but are at increased risk of HBV infection, receive periodic testing. Risk-based testing is expanded to include more conditions:
* People incarcerated or formerly incarcerated in a jail, prison, or other detention setting
* People with a history of sexually transmitted infections or multiple sex partners
* People with a history of hepatitis C virus infection
Anyone can be infected with hepatitis B. Because risk may be transient or unrecognized, all adults can benefit from knowing their status and being protected from infection. To provide increased access to testing, anyone who requests HBV testing should receive it, regardless of disclosure of risk. In addition to screening, CDC recommends vaccination of all people younger than age 60 years and all people age 60 or older at increased risk. Anyone age 60 or older may be vaccinated.
A person who is unvaccinated may have blood drawn for screening, followed by the first dose of vaccine at the same visit. If vaccination is indicated, it should not be delayed if screening is not feasible.
[link removed]
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Links
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
* CDC: Viral Hepatitis: Hepatitis B ([link removed]) main page
* Immunize.org: Vaccines: Hepatitis B ([link removed]) main page
------------------------------------------------------------
FDA approves intramuscular injection as an option, in addition to subcutaneous administration, for M-M-R II, Varivax, and ProQuad vaccines
The Food and Drug Administration (FDA) approved intramuscular (IM) injection as an option for M-M-R II (measles-mumps-rubella vaccine), Varivax (varicella vaccine), and ProQuad (measles-mumps-rubella-varicella vaccine) from Merck. Previously, these vaccines were only licensed for subcutaneous (subcut) injection.
Two brands of MMR vaccine are distributed in the United States. Only Merck’s brand is licensed for either IM or subcut administration. Priorix from GSK is licensed for subcut administration. In coming weeks, Immunize.org will update its resources on vaccine administration to reflect this new route of administration option.
Related Links
* FDA: Measles, Mumps, and Rubella Virus Vaccine Live (M-M-R II) ([link removed]) protect information
* FDA: Measles, Mumps, Rubella, and Varicella Virus ([link removed]) Live (ProQuad) ([link removed]) product information
* FDA: Varicella Virus Vaccine ([link removed]) (Varivax) ([link removed]) product information
* Merck press release: U.S. FDA Approves Intramuscular Administration for Merck’s MMRV Family of Vaccines: M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live), Varivax (Varicella Virus Vaccine Live), and ProQuad (Measles, Mumps, Rubella, and Varicella Virus Vaccine Live) ([link removed]) (3/6/23)
* Immunize.org: Food and Drug Administration: Package Inserts & FDA Product Approvals ([link removed]) main page
------------------------------------------------------------
March is Women’s History Month; Immunize.org celebrates the many contributions of women in vaccinology
March is Women's History Month ([link removed]) and Immunize.org acknowledges the important contributions of women to vaccinology. Since the beginning of the vaccine era, women contributed to vaccine science and vaccination programs globally. We celebrate women’s trailblazing contributions in vaccinology, including:
* Lady Mary Wortley Montagu introduced smallpox inoculation to Britain and Western Europe in 1721
* Anna Wessels Williams isolated the reference strain of diphtheria used to develop the first diphtheria antitoxin and later a diphtheria toxoid in the 1890s. She developed a quick test to diagnose rabies in 1902.
* Margaret Pittman recognized in 1931 that type b of Haemophilus influenzae was a major cause of disease
* Ida A. Bengtson developed the complement fixation test in the 1920s, which was used to standardize units of biological activity for botulinum, gas gangrene, and other antitoxins
* Pearl L. Kendrick and Grace Elderling researched pertussis in the 1940s, tested their vaccine first on themselves, and ran a successful clinical trial, resulting in the first vaccine against pertussis. Loney Clinton Gordon aided their efforts.
* Dorothy Horstmann showed that poliovirus reaches the brain through the blood in the 1940s
* Clara I. Nigg codeveloped botulinum toxoids in 1947
* Isabel M. Morgan and her team proved that inactivated viruses could produce immunity in the 1940s; her work led the development of Salk's polio vaccine in 1955
* Brigitte Alice Askonas's work on antibodies and T-cells in the 1950s informed research to improve vaccines
* Ruth L. Kirshstein helped develop and refine tests to assure the safety of viral vaccines against polio, measles, and rubella in the 1950s–1970s
* Özlem Türeci helped lead the development of the BioNTech/Pfizer COVID-19 vaccine in 2020
* Lisa Jackson led the world's first COVID-19 clinical vaccine trial in 2020
* Kizzmekia Corbett helped create the COVID-19 mRNA vaccine in 2020
* These are a few of the countless women contributing to vaccine development and the success of vaccination programs worldwide
[link removed]
The contributions of all of the women who work tirelessly to advance vaccine science, policy, and program implementation are deeply appreciated.
Related Links
* Women's History Month ([link removed]) website
* Gavi, the Vaccine Alliance: The Women Who Made Modern Vaccines Work ([link removed]) web page
* International Vaccine Institute: Celebration Women in Vaccines – International Day of Women and Girls in Science 2023 ([link removed]) web page
------------------------------------------------------------
Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
The Immunize.org reviews and updates the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) every month, prominently indicating when it was last updated at the top of the page. This month’s updates are minimal, including an updated FDA page on expiration dates and the date of the Immunize.org Vaccines: COVID-19 ([link removed]) main page.
All COVID-19 vaccination providers should review the checklist regularly to be sure practices stay up to date.
[link removed]
CDC posted a spotlight on influenza vaccine effectiveness (VE) ([link removed]) this season. Multiple estimates show that influenza vaccine provides substantial protection to children and adults this season against illness and hospitalization.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
------------------------------------------------------------
Influenza activity remains low nationally but is still circulating; keep encouraging vaccination
CDC continues to recommend influenza vaccination for those not yet protected as long as influenza is circulating. Keep in mind young children who still need a second dose in their first vaccination season and those who need vaccination during pregnancy.
CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , provides a valuable snapshot of influenza activity state by state. For week 9, ending March 4, FluView ([link removed]) reports that 2.4% of outpatient visits nationwide were due to respiratory illness that included fever plus a cough or sore throat (i.e., influenza-like illness [ILI]). The national baseline is 2.5%. Multiple respiratory viruses are co-circulating; the relative contribution of influenza virus infection to ILI varies by location. So far this season, 125 children died from influenza-associated causes.
[link removed]
Influenza Vaccination Dashboard
CDC’s Weekly Flu Vaccination Dashboard ([link removed]) shows that vaccination coverage for all children remains 2.3 percentage points lower compared with same time in February 2021 (53.0% compared with 55.3%). Where children live is strongly associated with how likely they are to be vaccinated: the influenza vaccination rate among rural children is 19.1 percentage points lower compared with children living in urban areas (37.5% compared with 56.7%).
CDC posted a spotlight on influenza vaccine effectiveness (VE) ([link removed]) this season. Multiple estimates show that this season, influenza vaccine provides substantial protection against illness and hospitalization to children and adults.
CDC recommends everyone age 6 months and older get annual influenza vaccination. “Vaccines.gov” offers VaccineFinder ([link removed]) , a service of Boston Children’s Hospital, to help people find influenza and COVID-19 vaccines for any age group. To be listed as a provider by VaccineFinder, see the information at this website ([link removed]) .
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: Influenza (Flu) ([link removed]) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
------------------------------------------------------------
Spotlight: Immunize.org's “Clinic Tools: Administering Vaccines” main page provides practical tools based on authoritative sources
Immunize.org's Clinic Tools: Administering Vaccines ([link removed]) main page is a collection of resources from Immunize.org, CDC, and other organizations. To find it, select the "Clinic Tools" tab in the middle of the blue banner atop every Immunize.org web page and then select "Administering Vaccines."
On the "Clinic Tools: Administering Vaccines" main page, you will find educational materials such as:
* Administering Vaccines: Dose, Route, Site, and Needle Size ([link removed])
* Don’t Be Guilty of These Preventable Errors in Vaccine Administration ([link removed])
* How to Administer Intramuscular and Subcutaneous Vaccine Injections ([link removed])
* Skills Checklist for Vaccine Administration ([link removed])
The right-hand column of the page features partner resources, links to vaccine administration guidelines, and The Epidemiology and Prevention of Vaccine-Preventable Diseases ("The Pink Book") textbook.
[link removed]
Visit the Clinic Tools: Administering Vaccines ([link removed]) main page on Immunize.org.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* AMA: Why COVID-19 Deaths among Vaccinated Show That Boosters Matter ([link removed]) (3/7/23)
* U.S. News: Highlighting Link between Flu & Heart Trouble Can Nudge Folks to Get Vaccine ([link removed] ) (3/7/23)
* ABC: MMR Vaccine Rates Are Lagging amid a Rise in Measles Cases. Experts Blame a Discredited Study. ([link removed]) (3/6/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates "Talking about Vaccines" web pages on alternative schedules, autism, and MMR vaccine
Immunize.org updated Talking about Vaccines: A ([link removed]) lternative Schedules ([link removed]) , Talking about Vaccines: Autism ([link removed]) , and Talking about Vaccines: MMR Vaccine ([link removed]) main pages. These pages lead to many resources from Immunize.org, CDC, and others to help healthcare professionals communicate with parents and patients about important vaccine topics.
The pages were updated to optimize links and content.
[link removed] [link removed] [link removed]
Related Links
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed]) —an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
* Immunize.org: Talking about Vaccines ([link removed]) main page
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Immunize.org posts 19 new and updated Vaccine Information Statements in Bengali
Immunize.org further expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. With CDC funding to increase the availability of translations, 19 new VIS translations were added in Bengali.
All translations are available in print-ready PDF format.
New VIS translations in Bengali ([link removed]) :
* Updated: DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Updated: Hepatitis A ([link removed]) VIS
* Updated: Hepatitis B ([link removed]) VIS
* Updated: Haemophilus influenzae type b (Hib) ([link removed]) VIS
* Updated: HPV (Human Papillomavirus) ([link removed]) VIS
* Updated: Influenza (Inactivated or Recombinant) ([link removed]) VIS
* Updated: Influenza (Live Intranasal) ([link removed]) VIS
* Updated: Meningococcal ACWY ([link removed]) VIS
* Updated: Meningococcal B ([link removed]) VIS
* Updated: MMR (Measles, Mumps, and Rubella) ([link removed]) VIS
* Updated: MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* Updated: Polio ([link removed]) VIS
* New! Rabies ([link removed]) VIS
* New! Rotavirus ([link removed]) VIS
* New! Smallpox/Monkeypox ([link removed]) VIS
* Updated: Td (Tetanus, Diphtheria) ([link removed]) VIS
* Updated: Tdap (Tetanus, Diphtheria, Pertussis) ([link removed]) VIS
* Updated: Varicella (Chickenpox) ([link removed]) VIS
* New! Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Bengali-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org posts 11 new and updated Vaccine Information Statements in Hmong
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. With CDC funding to increase the availability of translations, 11 new VIS translations were added in Hmong.
All translations are available in print-ready PDF format.
New VIS translations in Hmong ([link removed]) :
* New! DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Updated: Hepatitis A ([link removed]) VIS
* Updated: Hepatitis B ([link removed]) VIS
* Updated: Haemophilus influenzae type b (Hib) ([link removed]) VIS
* New! Meningococcal ACWY ([link removed]) VIS
* Updated: Meningococcal B ([link removed]) VIS
* Updated: Polio ([link removed]) VIS
* New! Rabies ([link removed]) VIS
* New! Smallpox/Monkeypox ([link removed]) VIS
* Updated: Td (Tetanus, Diphtheria) ([link removed]) VIS
* Updated: Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Hmong-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org posts 15 new and updated Vaccine Information Statements in Thai
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. With CDC funding to increase the availability of translations, 15 new VIS translations were added in Thai.
All translations are available in print-ready PDF format.
New VIS translations in Thai ([link removed]) :
* Updated: DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* New! Hepatitis A ([link removed]) VIS
* Updated: Hepatitis B ([link removed]) VIS
* New! Haemophilus influenzae type b (Hib) ([link removed]) VIS
* Updated: HPV (Human Papillomavirus) ([link removed]) VIS
* Updated: Meningococcal ACWY ([link removed]) VIS
* Updated: Meningococcal B ([link removed]) VIS
* Updated: MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* New! Polio ([link removed]) VIS
* New! Rabies ([link removed]) VIS
* New! Rotavirus ([link removed]) VIS
* New! Smallpox/Monkeypox ([link removed]) VIS
* New! Td (Tetanus, Diphtheria) ([link removed]) VIS
* Updated: Varicella (Chickenpox) ([link removed]) VIS
* Updated: Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Thai-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Society for Women’s Health Research releases video series to help people learn about HPV vaccine and cancer prevention
The Society for Women's Health Research launched its #SWHRtalksHPV Video Series ([link removed]) to help parents and guardians learn about cancer prevention via HPV vaccination. Experts share facts and insights as they answer key questions.
The series of ten videos features Immunize.org’s chief policy and partnerships officer, L.J Tan, PhD, MS.
[link removed]
Share the video series on social media and with your networks, and tag @SWHR and #SWHRtalksHPV.
Back to top (#Top)
------------------------------------------------------------
Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
[link removed] [link removed]
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
CHOP's Vaccine Education Center offers video on measles symptoms, spread, and complications
Children's Hospital of Philadelphia's (CHOP) Vaccine Education Center (VEC) offers Measles: Symptoms, Spread & SSPE ([link removed]) in its Doctors Talk video series. In this video, CHOP's Paul Offit, MD, and Katie Lockwood, MD, MEd, talk about measles, its symptoms, side effects, and physician worries when a child contracts measles.
[link removed]
Watch and share the video ([link removed]) .
Related Links
* CHOP VEC: A Look at Each Vaccine: Measles, Mumps and Rubella (MMR) Vaccine ([link removed]) web page
* CHOP VEC: Measles, Mumps & Rubella (MMR) Infographic ([link removed]) (PDF)
------------------------------------------------------------
Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available on-demand
On February 28, Immunize.org and Canadian experts from the Hospital for Sick Children (SickKids), Toronto, and Society for Infodemic Management, Québec, hosted a 1-hour webinar, Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults ([link removed]) . During this webinar, participants learned about the principles behind vaccination pain and anxiety and simple, evidence-based strategies to reduce apprehension. These strategies were developed by the experts from HELP Eliminate Pain in Kids and Adults ([link removed]) . Their work was used by the World Health Organization (WHO), Public Health Canada, and others to develop guidelines for reducing vaccination pain.
The video of the webinar, slide set, and web links to other resources are now available on our website for on-demand viewing ([link removed]) . Please view and share this important webinar with your colleagues.
[link removed]
Related Link
* Immunize.org: Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age ([link removed]) (webinar held on 12/13/22)
------------------------------------------------------------
Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident recommendations for influenza vaccine from healthcare providers are powerfully persuasive. To assist you in maximizing protection for your patients, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense ([link removed]) website.
Older adults are at increased risk of severe influenza and COVID-19 illness, including hospitalization and death, especially if they are not up to date on these vaccinations. An updated fact sheet on the website, The Importance of Preventing Influenza and COVID-19, ([link removed]) ([link removed]) offers responses to help guide discussions with patients on the importance of preventing influenza and COVID-19.
[link removed]
This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP ([link removed])
* The Importance of Preventing Influenza and COVID-19 ([link removed])
Check out the updated 65+ Flu Defense website at www.influenza-defense.org ([link removed]) to assist your ongoing efforts in protecting this vulnerable population.
------------------------------------------------------------
Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Download Immunize.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide is available to download/print either by chapter or in its entirety free at www.immunize.org/guide ([link removed]) . The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s educational materials (handouts) on adult immunization ([link removed])
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: NFID hosts webinar “Updates from February 2023 Advisory Committee on Immunization Practices (ACIP) Meeting” on March 22; CME available
The National Foundation for Infectious Diseases will host a webinar titled Updates from February 2023 Advisory Committee on Immunization Practices (ACIP) Meeting ([link removed]) , 12:00–1:00 p.m. (ET) on March 22. During the webinar, William Schaffner, MD, NFID Medical Director and ACIP liaison, and Jessica R. MacNeil, MPH, ACIP Deputy Executive Secretary, will discuss the updates to current U.S. vaccination recommendations for children, adolescents, and adults. Content will focus primarily on non-COVID-19-related topics.
There is no fee to participate in this activity, but pre-registration is required. CME available.
Register for the webinar ([link removed]) .
------------------------------------------------------------
Virtual: Massachusetts Adult Immunization Coalition hosts “28th Annual Massachusetts Adult Immunization Conference” on April 4; CME available
Massachusetts Adult Immunization Coalition (MAIC) will host its 28th Annual Massachusetts Adult Immunization Conference ([link removed]) virtually, 8:00 a.m.–4:00 p.m. (ET), on April 4. This year's theme is the future of vaccination.
The goal is to educate healthcare professionals on best practices for adult immunization. The 2023 conference offers an opportunity to receive the most updated information on routine adult immunization from leading experts and network with experts and colleagues.
Professionals outside of Massachusetts are encouraged to attend. First-time attendees get free registration; $50 for students and $75 for others. Up to 6.75 CME credits are available.
Register for the conference ([link removed]) .
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp